Vaccine-induced immune thrombotic thrombocytopenia: definition, risks with different vaccines, and regulatory responses

Vaccine-induced immune thrombotic thrombocytopenia: definition, risks with different vaccines, and regulatory responses

After the vaccination campaign initiation in Europe and the UK, reports of rare cases of atypical thrombosis, including sinus vein thrombosis and splanchnic venous thrombosis, began to appear in association with the use of vector vaccines AstraZeneca (ChAdOx1) and Johnson & Johnson/Janssen....

Full description

Bibliographic Details
Main Authors: S. V. Akinshina, V. O. Bitsadze, J. Kh. Khizroeva, K. N. Grigorieva, E. V. Slukhanchuk, M. V. Tretyakova, V. I. Tsibizova, I. Elalamy, J.-C. Gris, B. Brenner, E. Grandone, C. Ay, A. D. Makatsariya
Format: Article
Language:Russian
Published: IRBIS LLC 2021-11-01
Series:Акушерство, гинекология и репродукция
Subjects:
vaccine-induced immune thrombotic thrombocytopenia
vitt
thrombosis
coronavirus
sars-cov-2
covid-19
heparin-induced thrombocytopenia
hit
vaccination
Online Access:https://www.gynecology.su/jour/article/view/1098

Internet

https://www.gynecology.su/jour/article/view/1098

Similar Items